Showing results (131-140 of 289) with videos related to
Sort By:
Pageof 29
Immunity, Inflammation and Disease|May 12, 2021
A simple, sensitive, and low-cost FACS assay for detecting antibodies against the native SARS-CoV-2 spike proteinJulia Hambach, Tobias Stähler, Thomas Eden, et al.Scientific Reports|July 29, 2017
Hobit expression by a subset of human liver-resident CD56bright Natural Killer cellsSebastian Lunemann, Gloria Martrus, Hanna Goebels, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?Rasmi Thomas, Eriko Yamada, Galit Alter, et al.Journal of Virology|February 15, 2005
Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapyJ Judy Chang, Fiona Wightman, Angeline Bartholomeusz, et al.Plos Pathogens|March 23, 2011
KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motifArnaud D Colantonio, Benjamin N Bimber, William J Neidermyer, et al.The Journal of Clinical Investigation|March 20, 2002
Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infectionMarcus Altfeld, Jan van Lunzen, Nicole Frahm, et al.Journal of Virology|April 13, 2018
The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and ReversedSimin D Rezaei, Hao K Lu, J Judy Chang, et al.AIDS (London, England)|November 16, 2010
Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccineLaura Papagno, Galit Alter, Lambert Assoumou, et al.Virology|July 30, 2010
MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunctionAnne Nolting, Anne-Sophie Dugast, Suzannah Rihn, et al.Vaccine|August 24, 2010
Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant SystemsIsabel Leroux-Roels, Marguerite Koutsoukos, Frédéric Clement, et al.Pageof 29